SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConygar Inv Regulatory News (CIC)

Share Price Information for Conygar Inv (CIC)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £14.02m
CIC Live PriceLast checked at - London Stock Exchange

Intraday Conygar Inv Share Chart

Planning approved for bioscience development

18 May 2023 07:00

RNS Number : 8011Z
Conygar Investment Company PLC(The)
18 May 2023
 

 

 

 18th May 2023

THE CONYGAR INVESTMENT COMPANY PLC

Planning approved for bioscience development

at The Island Quarter, Nottingham

The Conygar Investment Company PLC ("Conygar") is pleased to announce that Nottingham City Council has approved its detailed application for the next phase of The Island Quarter development in Nottingham. The application comprises a 23,123 sq.m. (249,000 sq.ft.) bioscience building, which includes both laboratory and office space. The permission is subject to the documenting of the section 106 agreement.

Robert Ware, Chief Executive of Conygar, commented:

"We are delighted that the next phase of development has been approved. Nottingham is already home to a large number of exciting businesses in the bioscience space and this scheme will be an excellent addition to the mixed-use development we are creating at The Island Quarter".

Enquiries:

The Conygar Investment Company PLC

Robert Ware: 020 7258 8670 

Liberum Capital Limited (Nominated Adviser and Broker)

Richard Lindley: 020 3100 2185

Temple Bar Advisory (Public Relations)

Alex Child-Villiers: 07795 425580

William Barker: 07827 960151

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKDLFFXELXBBV
Date   Source Headline
11th Jun 200711:21 amRNSInterim Results
6th Jun 20071:13 pmRNSDisposal
2nd May 20075:34 pmRNSHolding(s) in Company
28th Feb 20077:00 amRNSVoting Rights and Capital
23rd Feb 20079:52 amRNSGrant of options
21st Feb 20075:43 pmRNSPlanning Application
21st Feb 200710:33 amRNSHolding(s) in Company
13th Feb 20075:03 pmRNSHolding(s) in Company
2nd Feb 20074:49 pmRNSDisposal
2nd Feb 20074:49 pmRNSHolding(s) in Company
29th Jan 20077:01 amRNSIssue of Equity
11th Jan 20075:08 pmRNSResult of AGM
21st Dec 20063:20 pmRNSDisposal
19th Dec 20067:01 amRNSFinal Results
18th Dec 200611:25 amRNSVoting rights and capital
13th Nov 20065:52 pmRNSHolding(s) in Company
27th Oct 20067:01 amRNSIssue of Equity
18th Oct 200612:58 pmRNSAcquisition
4th Oct 20061:59 pmRNSAcquisition
25th Jul 20064:14 pmRNSChange of Address
13th Jun 20067:00 amRNSInterim Results
16th May 20067:00 amRNSCompletion of acquisition
2nd May 20067:01 amRNSAcquisition
20th Mar 20067:10 amRNSGrant of options
20th Mar 20067:02 amRNSRe Placing and Board
9th Mar 20067:01 amRNSIssue of Equity
1st Feb 20064:39 pmRNSResult of AGM
2nd Dec 20057:00 amRNSFinal Results
30th Nov 20057:01 amRNSAcquisition of interest
9th Aug 20054:25 pmRNSDisposal
20th Jul 20057:15 amRNSDisposal by joint venture
29th Jun 200512:50 pmRNSInterim Results
26th Jan 20054:39 pmRNSResult of AGM
24th Jan 20051:47 pmRNSChange of Registered Office
24th Jan 20059:05 amRNSAcquisition
20th Jan 20054:36 pmRNSGrant of Options
19th Jan 20057:00 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.